United States · Pharmaceuticals startup

Genexa

Genexa is a clean medicine company founded in 2014 by David Johnson and Max Spielberg.

Funding reportedLast round: Series A

PharmaceuticalsAtlanta, United States

About Genexa

Genexa is a clean medicine company founded in 2014 by David Johnson and Max Spielberg.

The company aims to transform the medicine aisle by offering over-the-counter medicines that contain the same active ingredients as traditional options but without artificial fillers, dyes, or allergens. Genexa focuses on providing safe and effective products that align with family values, particularly for parents seeking cleaner alternatives for their children. The product range includes homeopathic and conventional formulations for pain, fever, cold, flu, and allergies. Notable offerings include Infants’ Acetaminophen Pain & Fever Oral Suspension and APAP for cold and flu symptoms. All products are free from artificial dyes, flavors, and preservatives, and are certified USDA Organic and Non-GMO Project Verified. Genexa primarily targets parents and health-conscious consumers, emphasizing transparency and ingredient quality. The company has also engaged healthcare providers and retailers through sampling programs and partnerships.

What company datasets say Genexa raised

Funding, as reported

Reported in all$60Min dollars
Rounds1
Last roundSeries A
Last round size$60M
Last round dateJul 2021
Investors listed23

Founders and team

From Genexa's own website: 2 founders.

David JohnsonCEO & Founder
Max SpielbergCo-Founder

On 2 portfolio pages

Investors who name them

Each firm lists Genexa on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

The company, in detail

What they build

Known for

fever reducerartificial dye-freehealth caredye-freecertified gluten-freemedical advisory boardfamily wellnessallergy medicationconsumersdigestive healthnatural cold remediestransparent labelingactive ingredientsinactive ingredientsartificial preservative eliminationdisruptor

Built with from their website

Amazon Pay for BusinessMonetateGoogle Tag Managerparallax.jsKlaviyoFont AwesomeCloudFlareViewport MetaElement UIHubspot

+8 more

Zendesk ChatFacebook SDKYotpoApple Business ManagerTwilio SendGrid Email Marketing CampaignsPriority HintsMicrosoft ExchangeApple Pay

Sector
Pharmaceuticals
Industry code
NAICS 325412, SIC 2834
Region
Georgia
Revenue
$1.0M a year, as listed
Full record
Every detail in the company directory

Pharmaceuticals in United States

Startups like it

Is this your company?

Add your raise, your deck and your story, and put Genexa in front of investors. Or tell us what we have wrong.